Want to join the conversation?
$EFX expects ongoing investments to deliver long-term average organic revenue growth in the range of 6-8% with additional growth of 1-2% derived from strategic acquisitions consistent with long-term business strategy. $EFX expects to grow EPS at a somewhat faster rate than revenue over time as a result of both operating and financial leverage.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.